streptococc
pharyng
classic
infecti
diseas
childhood
one
common
best
studi
childhood
ill
recommend
pain
relief
major
aspect
manag
sore
throat
determin
whether
patient
treat
pharyng
infect
caus
group
streptococcu
gabh
determin
whether
pharyng
caus
gabh
done
cultur
pharyng
exud
blood
agar
plate
rapid
identif
gabh
antigen
use
commerci
kit
practition
may
tri
diagnos
streptococc
pharyng
clinic
clue
lack
adequ
specif
fact
acut
pharyng
caus
consider
often
virus
bacteria
virus
commonli
caus
pharyng
includ
influenza
viru
parainfluenza
viru
rhinoviru
coronaviru
adenoviru
respiratori
syncyti
viru
viru
enterovirus
herpesvirus
caus
acut
pharyng
includ
group
c
g
streptococci
mycoplasma
pneumonia
less
commonli
neisseria
gonorrhoea
chlamydia
pneumonia
arcanobacterium
hemolyticum
critic
evalu
determin
clinic
relev
van
driel
et
al
discuss
make
diagnosi
pharyng
due
gabh
make
diagnosi
treat
patient
antibiot
note
van
driel
et
al
previou
cochran
review
found
modest
symptomat
benefit
treat
pharyng
even
due
gabh
fact
decad
convent
wisdom
antibiot
treatment
benefit
alter
symptom
associ
gabh
pharyng
reason
treat
prevent
rheumat
fever
krober
et
al
randolph
et
al
publish
control
studi
suffici
proof
clinic
efficaci
investig
took
serious
question
antibiot
work
best
reduc
symptom
dilemma
face
investig
studi
impact
antibiot
prevent
acut
rheumat
fever
rariti
acut
rheumat
fever
technolog
advanc
countri
studi
perform
difficulti
follow
patient
forward
develop
countri
acut
rheumat
fever
still
rel
common
penicillin
variou
form
antibiot
shown
prevent
rheumat
therefor
newer
studi
compar
effect
differ
antibiot
gabh
pharyng
reli
surrog
endpoint
clinic
respons
erad
gabh
throat
relaps
microbiolog
clinic
data
correl
surrog
endpoint
prevent
acut
rheumat
fever
lack
nevertheless
author
question
wisdom
continu
recommend
penicillin
first
choic
treat
gabh
pharyng
publish
studi
perform
best
use
surrog
endpoint
author
studi
point
endpoint
rather
surrog
prevent
acut
rheumat
fever
import
even
short
relief
acut
pharyng
erad
gabh
throat
cultur
perform
day
therapi
clinic
import
argument
base
primarili
relaps
rate
also
symptomat
endpoint
promot
casey
et
al
author
question
wisdom
american
heart
associ
american
academi
pediatr
infecti
diseas
societi
america
recommend
penicillin
antibiot
gabh
pharyng
respons
opinion
base
surrog
endpoint
publish
gabh
point
data
support
increas
resist
gabh
pharyng
penicillin
appar
superior
newer
antibiot
owe
better
erad
gabh
throat
carrier
clinic
relev
studi
refer
casey
et
al
signific
methodolog
flaw
newest
version
recommend
american
heart
associ
amoxicillin
recommend
equal
favourit
oral
penicillin
g
administr
associ
better
patient
given
context
import
van
driel
et
al
look
studi
compar
differ
antibiot
efficaci
gabh
abil
prevent
acut
rheumat
fever
endpoint
resolut
symptom
relaps
side
effect
antibiot
erad
gabh
throat
strength
review
chose
studi
meet
high
standard
studi
design
address
issu
carrier
studi
popul
mention
would
contribut
clinic
endpoint
disagre
carrier
may
enter
studi
mistaken
belief
acut
pharyng
due
gabh
lack
clinic
respons
may
result
pharyng
due
agent
probabl
viru
respons
antibiot
howev
analysi
support
use
penicillin
first
choic
gabh
comparison
antibiot
antibiot
class
effect
clinic
agent
price
safeti
lack
antibiot
resist
make
prefer
treatment
agent
find
favour
cephalosporin
effect
prevent
relaps
chang
conclus
appli
adult
gabh
pharyng
uncommon
problem
number
need
treat
show
benefit
high
find
consid
meaning
relev
support
grant
consult
